MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1523/jneurosci.0341-17.2017

Медицинская библиотека · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017

Opening a New Time Window for Treatment of Stroke by Targeting HDAC2.

Lin Yu-Hui, Dong Jian, Tang Ying, Ni Huan-Yu, Zhang Yu, Su Ping, Liang Hai-Ying, Yao Meng-Cheng, Yuan Hong-Jin, Wang Dong-Liang, Chang Lei, Wu Hai-Yin, Luo Chun-Xia, Zhu Dong-Ya

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Narrow therapeutic window limits treatments with thrombolysis and neuroprotection for most stroke patients. Widening therapeutic window remains a critical challenge. Understanding the key mechanisms underlying the pathophysiological events in the peri-infarct area where secondary injury coexists with neuroplasticity over days to weeks may offer an opportunity for expanding the therapeutic window. Here we show that ischemia-induced histone deacetylase 2 (HDAC2) upregulation from 5 to 7 d after stroke plays a crucial role. In this window phase, suppressing HDAC2 in the peri-infarct cortex of rodents by HDAC inhibitors, knockdown or knock-out of Hdac2 promoted recovery of motor function from stroke via epigenetically enhancing cells survival and neuroplasticity of surviving neurons as well as reducing neuroinflammation, whereas overexpressing HDAC2 worsened stroke-induced functional impairment of both WT and Hdac2 conditional knock-out mice. More importantly, inhibiting other isoforms of HDACs had no effect. Thus, the intervention by precisely targeting HDAC2 in this window phase is a novel strategy for the functional recovery of stroke survivors.SIGNIFICANCE STATEMENT Narrow time window phase impedes current therapies for stroke patients. Understanding the key mechanisms underlying secondary injury may open a new window for pharmacological interventions to promote recovery from stroke. Our study indicates that ischemia-induced histone deacetylase 2 upregulation from 5 to 7 d after stroke mediates the secondary functional loss by reducing survival and neuroplasticity of peri-infarct neurons as well as augmenting neuroinflammation. Thus, precisely targeting histone deacetylase 2 in the window phase provides a novel therapeutic strategy for stroke recovery.

Для цитирования: Lin Yu-Hui, Dong Jian, Tang Ying, Ni Huan-Yu, Zhang Yu, Su Ping, Liang Hai-Ying, Yao Meng-Cheng, Yuan Hong-Jin, Wang Dong-Liang, Chang Lei, Wu Hai-Yin, Luo Chun-Xia, Zhu Dong-Ya. Opening a New Time Window for Treatment of Stroke by Targeting HDAC2.. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2017. DOI: 10.1523/jneurosci.0341-17.2017.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.